NCI
The researchers found biomarkers of macrophage activity and immune activity were associated with resistance and response to Opdivo plus Cabometyx.
NIH Funding Cuts Threaten Research, Clinical Trials, Precision Oncology Progress, Leaders Say
Premium
Researchers warn NIH divestment from research could hinder progress at a pivotal moment for advances in precision cancer medicine.
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
Aptose Partners With NCI to Study Tuspetinib in MyeloMATCH Trials
NCI will include the multi-kinase inhibitor in the umbrella trial evaluating targeted therapy combinations in AML and MDS patients.
Marengo Therapeutics Advancing Bispecific Antibody to Phase II After Positive First-in-Human Data
Premium
A Phase I study of invikafusp alfa presented at SITC provided the rationale to enroll patients with TMB-high, MSI-high, and virus-associated tumors in Phase II.
May 21, 2024
Mar 14, 2024
Jul 10, 2023
Jun 1, 2023